Related Articles
Identification of candidate genes associated with tubal origin of high‑grade serous ovarian cancer
Expression and clinical significance of methyl‑CpG binding domain protein 2 in high‑grade serous ovarian cancer
Metronomic cyclophosphamide‑induced long‑term remission after recurrent high‑grade serous ovarian cancer: A case study
Intratumoral expression analysis reveals that OX40 and TIM‑3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer
A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer